Patent Assignment
Reel/Frame 058217/0201
Change of Name
Recorded: 2021-11-27
Pages: 11
Assignor
NESTLÉ SKIN HEALTH S.A.
Executed: 2020-01-29
Assignee
GALDERMA HOLDING SA
RUE D'ENTRE-DEUX-VILLES, 10, LA TOUR-DE-PEILZ, 1814, SWITZERLAND
Covered Property
(1)
Nemolizumab in the Treatment of Atopic Dermatitis with Moderate to Severe Excoriation
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 27, 2021
From: KERROUCHE, NABIL
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058217/0169 →
Assignment of Assignor's Interest
Nov 27, 2021
From: KERROUCHE, NABIL
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058217/0184 →
Assignment of Assignor's Interest
Nov 27, 2021
From: HIROKAWA, KEIKO
To: CHUGAI SEIYAKU KABUSHIKI KAISHA
Reel/Frame 058217/0187 →
Assignment of Assignor's Interest
Nov 27, 2021
From: MIHARA, RYOSUKE
To: CHUGAI SEIYAKU KABUSHIKI KAISHA
Reel/Frame 058217/0192 →
Corrective Assignment to Correct the Application Number 16907132 Previously Recorded at Reel: 058217 Frame: 0169. Assignor(S) Hereby Confirms the Assignment .
Apr 28, 2022
From: KERROUCHE, NABIL
To: NESTLE SKIN HEALTH SA
Reel/Frame 059820/0089 →
Change of Address
Jun 27, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 061113/0710 →